Background
==========

Snake venom is a cocktail of biologically active proteins with multifarious pharmacological effects representing the inverse of the physiological processes that maintain prey homeostasis \[[@B1]\]. Venom defines the ecology, life history, and evolution of venomous species due to its involvement in prey capture, digestion, and defense \[[@B1]\]. Positive selection has been repeatedly detected in toxin genes and reflects the significant contribution of venoms to fitness \[[@B2]-[@B4]\]. These molecular signals of adaptive evolution coupled with compositional variation suggest that toxin diversification is an adaptation to diet and may reflect a predator-prey arms race \[[@B5]\]. Snake venom components exert selective pressures on both prey \[[@B6],[@B7]\] and predators \[[@B1]\], and potentially offer a unique, dual perspective on predator-prey coevolution.

New World coral snakes (Elapidae) consist of three genera (*Leptomicrurus, Micrurus,* and *Micruroides*) and over 120 species and subspecies, inhabiting a diverse array of habitats from the southern United States to central Argentina \[[@B8]\]. The eastern coral snake (*Micrurus fulvius*) is native to the forests of the southeastern United States and is mainly ophiophagous, preying upon smaller snakes and other squamates \[[@B9]\]. Bites from *Micrurus* species can be lethal \[[@B10]\] due to the pre- and postsynaptic effects of the neurotoxic venom components that dominate coral snake venoms (LD~50~ = 7--76 *μ*g venom/18--22 g mouse \[[@B11]\]), and polyvalent antivenom has been shown to be ineffective at treating bites from all *Micrurus* species \[[@B11],[@B12]\] and is currently unavailable in the United States \[[@B10]\]. A full characterization of all venom components may allow the design of more effective polyvalent antivenom \[[@B13],[@B14]\], but coral-snake venom composition is poorly understood in comparison to that of Old World elapids \[[@B15]\], mainly due to the difficulty of procuring sufficient venom quantities during milking for standard proteomic techniques \[[@B13]\]. High-throughput sequencing approaches are capable of identifying thousands of loci, enabling a detailed examination of the evolutionary forces shaping venom composition at the molecular level. We describe the first high-throughput transcriptomic characterization of an elapid venom gland to date. We sequenced the venom-gland transcriptome of *M. fulvius* with Illumina technology using the paired-end approach of Rokyta et al. \[[@B16]\], and used the generated sequence data to examine the relationship between toxin heterozygosity and gene duplication events and uncover distinct expression patterns in highly expressed and extremely diverse toxin gene families.

Results and discussion
======================

High venom complexity revealed by means of sequencing
-----------------------------------------------------

Our high-throughput transcriptomic analysis revealed high venom complexity in *M. fulvius*, comparable to the diversity of toxin components recently identified in the venom-gland transcriptome of the eastern diamondback rattlesnake (*Crotalus adamanteus*: Viperidae) \[[@B16]\]. We generated 79,573,048 pairs of 100 nucleotide raw reads and merged 61,609,456 pairs on the basis of overlap at their 3' ends, following the approach of Rokyta et al. \[[@B16]\] and Rodrigue et al. \[[@B17]\]. These merged reads had an average length of 134 nucleotides with average phred scores of 46. The iterative assembly process described by Rokyta et al. \[[@B16]\] coupled with a reference-based assembly using nontoxin transcripts previously described in the venom-gland transcriptome of *C. adamanteus* resulted in the identification of 1,950 unique, full-length nontoxin coding sequences and 116 unique, full-length toxin coding transcripts (Figure [1](#F1){ref-type="fig"}A).

![**The venom-gland transcriptome of*Micrurus fulvius*was extremely biased towards toxin production.** The venom-gland transcriptome of *M. fulvius* was dominated by toxin transcripts and, in particular, phospholipases A~2~ (PLA~2~s). **(A)** A total of 1,950 nontoxin-encoding and 116 toxin-encoding transcripts were identified. Toxins were grouped into 75 clusters based on \<1% nucleotide divergence. The inset shows a magnification of the top 200 transcripts, the vast majority of which code for toxins. **(B)** Expression levels of individual toxin clusters, color coded by toxin class. The 75 toxin clusters represent 15 distinct toxin classes. Three-finger toxin and PLA~2~ transcripts dominated toxin expression levels, accounting for nearly 86% of all toxin reads. Toxin-class abbreviations are as follows: 3FTx: three-finger toxin; CTL: C-type lectin; CREGF: cysteine-rich with EGF-like domain; HYAL: hyaluronidase; KUN: Kunitz-type protease inhibitor; LAAO: L amino-acid oxidase; LCN: long-chain neurotoxin; NGF: nerve growth factor; NP: natriuretic peptide; NUC: nucleotidase; PDE: phosphodiesterase; PLA~2~: phospholipase A~2~; PLB: phospholipase B; SVMP: snake venom metalloproteinase; VEGF: vascular endothelial growth factor.](1471-2164-14-531-1){#F1}

Transcript abundances were estimated by mapping 10 million reads to unique, full-length sequences with a minimum match percentage of 95% as described in Rokyta et al. \[[@B16]\] for *C. adamanteus*, against whose results we will be making comparisons. Toxin transcripts were grouped into clusters based on \<1% nucleotide divergence for abundance estimates. This enabled us to account for allelic variation, recent duplication events, and possible sequencing errors while also allowing reads to be mapped to a unique sequence rather than to multiple sequences, resulting in a more accurate estimation of abundance levels. Our estimates of abundance reflect mRNA levels and not necessarily protein abundances; the relationship between mRNA and protein levels is not always straightforward \[[@B18]\], and the construction of a complete genotype-phenotype map requires proteomic analyses (e.g., mass spectrometry).

The 1,950 nontoxin transcripts accounted for 11.3% of the reads. The 116 full-length toxin transcripts were grouped into 75 clusters (Figure [1](#F1){ref-type="fig"}B, Table [1](#T1){ref-type="table"}) and accounted for 45.8% of the reads. In total, we accounted for 57.1% of the reads (Figure [2](#F2){ref-type="fig"}), comparable to the amount identified for *C. adamanteus* using a similar approach \[[@B16]\]. While the overall percentage of reads mapping to identified transcripts was similar for *M. fulvius* and *C. adamanteus*, toxin expression levels were quite different (Figure [2](#F2){ref-type="fig"}). The toxin transcripts identified in *M. fulvius* accounted for nearly half of the total sequencing reads (45.8%) while the toxin transcripts in *C. adamanteus* accounted for approximately one-third (35.4%) of the total reads (Figure [2](#F2){ref-type="fig"}) \[[@B16]\]. The numbers and abundances of nontoxin coding sequences were much lower in *M. fulvius* than in *C. adamanteus*, despite an increase in assembly effort (e.g., the addition of the reference-based assembly), as 1,950 nontoxin transcripts accounted for 11.3% of the total reads in *M. fulvius* while 2,879 nontoxin transcripts accounted for 27.5% of the total reads in *C. adamanteus* (Figure [2](#F2){ref-type="fig"}). The venom-gland transcriptome of *C. adamanteus* was characterized by large, hemorrhage-inducing toxins such as snake venom metalloproteinases (SVMPs), proteins that presumably require extensive downstream processing by nontoxin machinery prior to becoming mature, active toxins \[[@B16]\]. The vast majority of highly expressed nontoxin sequences identified in the transcriptome of *C. adamanteus* were involved with proteostasis (e.g., protein folding, degradation, and transport) \[[@B16]\], and the reduction in the expression levels of nontoxin transcripts in *M. fulvius* could potentially reflect a difference in the maintenance, production, and folding requirements of the venom components of each species. The venom of *M. fulvius* was dominated by three-finger toxins (3FTxs) and phospholipases A~2~ (PLA~2~s), relatively short toxins that may not require the degree of downstream processing needed by larger toxins to become functional. This suggests that venoms dominated by smaller proteins differ in the transcriptional effort expended on toxins relative to nontoxins in comparison to venoms characterized by high-molecular weight components, with small-component venoms expressing toxins at much higher levels relative to nontoxin production. The largely proteinaceous composition of venom makes it metabolically costly to produce \[[@B19]\], and a reduction in the machinery necessary for the production of functional toxic proteins may confer an energetic benefit to species expressing smaller peptides and enzymes. Simple, smaller toxins have a reduced mutational target relative to larger proteins as a function of sequence length, potentially reducing the ability to evolve effective counterdefenses to resistance development in frequently envenomed prey \[[@B6],[@B7]\] and predators \[[@B1]\] where more complex venoms would be advantageous. However, as our hypotheses are based on a comparison between a single representative of each family, sequencing additional members of Viperidae and Elapidae are needed to test whether these putative differences in transcriptional effort are fixed or unique to *M. fulvius* and/or *C.adamanteus*.

###### 

Expression levels of toxin clusters

   **Rank**   **Cluster name**   **Cluster size**   **Length**   **% toxin reads**   **% total reads**   **GenBank accession numbers**
  ---------- ------------------ ------------------ ------------ ------------------- ------------------- -------------------------------
      1           PLA~2~-2              11             643             5.366               2.455                a: GAEP01002032
                                                                                                                b: GAEP01002033
                                                                                                                c: GAEP01002034
                                                                                                                d: GAEP01002035
                                                                                                                e: GAEP01002036
                                                                                                                f: GAEP01002037
                                                                                                                g: GAEP01002038
                                                                                                                h: GAEP01002039
                                                                                                                i: GAEP01002040
                                                                                                                j: GAEP01002041
                                                                                                                k: GAEP01002042
      2           PLA~2~-5              2              826             5.294               2.422                a: GAEP01002053
                                                                                                                b: GAEP01002054
      3          PLA~2~-16              1              815             5.036               2.304                 GAEP01002014
      4            3FTx-2               6              616             4.803               2.197                a: GAEP01001961
                                                                                                                b: GAEP01001962
                                                                                                                c: GAEP01001963
                                                                                                                d: GAEP01001964
                                                                                                                e: GAEP01001965
                                                                                                                f: GAEP01001966
      5           PLA~2~-1              4              809             4.195               1.919                a: GAEP01002018
                                                                                                                b: GAEP01002019
                                                                                                                c: GAEP01002020
                                                                                                                d: GAEP01002021
      6          PLA~2~-17              1              681             3.541               1.620                 GAEP01002015
      7            3FTx-1               4              394             3.424               1.567                a: GAEP01001957
                                                                                                                b: GAEP01001958
                                                                                                                c: GAEP01001959
                                                                                                                d: GAEP01001960
      8            3FTx-3               2              532             3.327               1.522                a: GAEP01001967
                                                                                                                b: GAEP01001968
      9          PLA~2~-11              1             1,534            3.162               1.447                 GAEP01002009
      10         PLA~2~-12              1              776             3.031               1.387                 GAEP01002010
      11           SVMP-1               1             2,323            2.947               1.348                 GAEP01002063
      12          PLA~2~-4              6              702             2.924               1.338                a: GAEP01002047
                                                                                                                b: GAEP01002048
                                                                                                                c: GAEP01002049
                                                                                                                d: GAEP01002050
                                                                                                                e: GAEP01002051
                                                                                                                f: GAEP01002052
      13         PLA~2~-26              1              638             2.856               1.307                 GAEP01002028
      14         PLA~2~-24              1              760             2.835               1.297                 GAEP01002026
      15         PLA~2~-14              1             1,074            2.801               1.281                 GAEP01002012
      16           3FTx-4               2              568             2.617               1.197                a: GAEP01001969
                                                                                                                b: GAEP01001970
      17          PLA~2~-3              2              874             2.278               1.042                a: GAEP01002045
                                                                                                                b: GAEP01002046
      18          PLA~2~-8              1             1,846            2.001               0.915                 GAEP01002060
      19         PLA~2~-29              1              487             1.913               0.875                 GAEP01002031
      20           3FTx-6               1              382             1.873               0.857                 GAEP01001973
      21          PLA~2~-6              3              681             1.860               0.851                a: GAEP01002055
                                                                                                                b: GAEP01002056
                                                                                                                c: GAEP01002057
      22         PLA~2~-20              1              825             1.518               0.695                 GAEP01002022
      23         PLA~2~-23              1              876             1.425               0.652                 GAEP01002025
      24          PLA~2~-7              2              782             1.411               0.645                a: GAEP01002058
                                                                                                                b: GAEP01002059
      25         PLA~2~-27              1              550             1.361               0.623                 GAEP01002029
      26         PLA~2~-28              1              565             1.333               0.610                 GAEP01002030
      27         PLA~2~-13              1              754             1.302               0.596                 GAEP01002011
      28         PLA~2~-30              1              730             1.182               0.541                 GAEP01002043
      29           3FTx-7               1              603             1.145               0.524                 GAEP01001974
      30          PLA~2~-9              1              631             1.097               0.502                 GAEP01002061
      31         PLA~2~-22              1              666             1.006               0.460                 GAEP01002024
      32           3FTx-9               1              593             0.992               0.454                 GAEP01001976
      33           LCN-4                1              471             0.985               0.451                 GAEP01001999
      34         PLA~2~-25              1              515             0.897               0.410                 GAEP01002027
      35           LAAO-1               3             2,359            0.880               0.403                a: GAEP01001991
                                                                                                                b: GAEP01001992
                                                                                                                c: GAEP01001993
      36         PLA~2~-19              1              985             0.798               0.365                 GAEP01002017
      37           LCN-1                3              613             0.795               0.364                a: GAEP01001994
                                                                                                                b: GAEP01001995
                                                                                                                c: GAEP01001996
      38           CTL-1                2              939             0.790               0.361                a: GAEP01001978
                                                                                                                b: GAEP01001979
      39          3FTx-11               1              496             0.784               0.359                 GAEP01001952
      40           KUN-2                1              551             0.782               0.358                 GAEP01001984
      41         PLA~2~-15              1              620             0.754               0.345                 GAEP01002013
      42         PLA~2~-31              1              506             0.720               0.330                 GAEP01002044
      43            NP-1                1              642             0.701               0.321                 GAEP01002005
      44           LCN-3                1              591             0.673               0.309                 GAEP01001998
      45           VEGF-1               1             4,642            0.629               0.288                 GAEP01002064
      46           KUN-1                2              421             0.600               0.274                a: GAEP01001982
                                                                                                                b: GAEP01001983
      47           NGF-1                2             1,014            0.576               0.264                a: GAEP01002003
                                                                                                                b: GAEP01002004
      48         PLA~2~-18              1              651             0.576               0.263                 GAEP01002016
      49          3FTx-14               1              377             0.522               0.239                 GAEP01001955
      50           LCN-6                1              548             0.504               0.231                 GAEP01002001
      51          3FTx-12               1              605             0.448               0.205                 GAEP01001953
      52          3FTx-13               1              492             0.439               0.201                 GAEP01001954
      53           LCN-2                1              734             0.390               0.179                 GAEP01001997
      54          3FTx-10               1              417             0.371               0.170                 GAEP01001951
      55           LCN-5                1              487             0.345               0.158                 GAEP01002000
      56           LCN-7                1              371             0.339               0.155                 GAEP01002002
      57           PLB-1                1             1,790            0.337               0.154                 GAEP01002062
      58         PLA~2~-21              1              668             0.325               0.149                 GAEP01002023
      59           KUN-7                1              442             0.303               0.139                 GAEP01001989
      60           KUN-3                1              442             0.284               0.130                 GAEP01001985
      61           VEGF-2               1             1,260            0.248               0.113                 GAEP01002065
      62           NUC-1                1             2,297            0.226               0.103                 GAEP01002006
      63          3FTx-15               1              625             0.202               0.092                 GAEP01001956
      64           HYAL-1               1             1,448            0.195               0.089                 GAEP01001981
      65           VEGF-3               1             1,422            0.171               0.078                 GAEP01002066
      66           3FTx-8               1              707             0.131               0.060                 GAEP01001975
      67           PDE-1                1             3,003            0.114               0.052                 GAEP01002007
      68           KUN-8                1              571             0.072               0.033                 GAEP01001990
      69           KUN-5                1              400             0.063               0.029                 GAEP01001987
      70         PLA~2~-10              1             1,120            0.055               0.025                 GAEP01002008
      71           3FTx-5               2             1,680            0.051               0.023                a: GAEP01001971
                                                                                                                b: GAEP01001972
      72           KUN-6                1              304             0.026               0.012                 GAEP01001988
      73           KUN-4                1              856             0.024               0.011                 GAEP01001986
      74          CREGF-1               1             1,573            0.014               0.007                 GAEP01001977
      75           CTL-2                1             1,020            0.009               0.004                 GAEP01001980

![**The venom-gland transcriptome of*Micrurus fulvius*was dominated by phospholipases A**~**2**~**and three-finger toxins.** Toxin gene expression was dominated by phospholipases A~2~ (PLA~2~s) and three-finger toxins (3FTxs). Full-length transcripts accounted for 57.1% of the total reads; toxin sequences accounted for 45.8% of the total reads. PLA~2~s and 3FTxs represent both the most abundant and most diverse toxin classes identified; 31 PLA~2~ clusters accounted for 64.9% of the toxin reads, and 15 3FTx clusters accounted for 21.1% of the toxin reads. Toxin sequences accounted for 10.4% more of the total reads in *M. fulvius* than in *C. adamanteus*, while nontoxins in *C. adamanteus* accounted for more than twice the total read percentage than in *M. fulvius*. The venom of *M. fulvius* was dominated by small neurotoxic components while the venom of *C. adamanteus* was dominated by larger hemorrhage-inducing proteins, suggesting that the transcriptional effort expended on toxins versus nontoxins may differ between venoms dominated by high-molecular weight components and venoms dominated by smaller proteins, with small-component venoms expressing toxins at much higher levels relative to nontoxin production.](1471-2164-14-531-2){#F2}

Toxin class expression patterns
-------------------------------

We identified 116 unique, full-length toxin transcripts representing 15 toxin classes or families which clustered into 75 groups with \<1% nucleotide divergence. Clusters could include alleles, recent duplicates, or assembly/sequencing errors. These clusters accounted for 45.8% of the total reads (Figure [2](#F2){ref-type="fig"}), and nearly all of the high-abundance transcripts coded for toxins (Figure [1](#F1){ref-type="fig"}A). Of the 75 toxin clusters identified, 71 were among the top 200 most highly expressed genes (Figure [1](#F1){ref-type="fig"}A), while only 63 of the 78 toxin clusters identified in *C. adamanteus* were among the top 200 most highly expressed genes \[[@B16]\]. The expression patterns of the venom gland appear to be biased towards toxin production in *C. adamanteus*, but reach a more extreme level of specialization in *M. fulvius*. Although sequencing a single specimen may not accurately reflect gene expression for all individuals of *M. fulvius*, our analyses provide a reference transcriptome for future work with the species. We used the number of reads mapping to a specific transcript as an estimate of its abundance as per Rokyta et al. \[[@B16]\]. Toxin transcripts were named by the toxin-class abbreviation followed by the cluster number and a letter if multiple transcripts were present within the cluster.

### Phospholipases A~2~

We identified 54 unique sequences of PLA~2~s that grouped into 31 clusters, which accounted for 64.9% of toxin reads and 29.7% of the total reads (Figure [2](#F2){ref-type="fig"}). PLA~2~s were the most abundant and diverse toxin class in the *M. fulvius* venom-gland transcriptome. PLA~2~s are esterolytic en- zymes and are among the most toxic components of snake venoms, causing pre- and postsynaptic neurotoxicity, myotoxicity, cardiotoxicity, hemolytic activity, anticoagulant activity, and hypotensive activity among other effects \[[@B20]\]. Conversely, SVMPs were the most abundant toxin gene family in *C. adamanteus*, with 16 clusters representing 39 sequences accounting for 24.4% of the toxin reads and 8.6% of the total reads \[[@B16]\]. PLA~2~s accounted for more than twice the percentage of toxin reads and over three times the percentage of total reads than the most abundant class in *C. adamanteus*, demonstrating the extreme dominance of gene expression by the PLA~2~ gene family in *M. fulvius*.

### Three-finger toxins

We identified 26 full-length transcripts and 15 clusters of 3FTxs, which accounted for 21.1% of toxin reads and 9.7% of the total reads (Figure [2](#F2){ref-type="fig"}). 3FTxs were the second most abundant and diverse toxin class, and with PLA~2~s accounted for 86.0% of the total toxin reads. 3FTxs are short (60--71 amino-acid residues), nonenzymatic proteins characterized by three *β*-stranded loops extending from a center protein core \[[@B21]\]. These proteins are common components of elapid snake venoms and exhibit postsynaptic neurotoxicity by inhibiting the binding of acetylcholine to the muscle nicotinic acetylcholine receptors, causing a blockage of neuromuscular transmission \[[@B21]\]. The venom-gland transcriptome of *M. altirostris* was dominated by 3FTxs, as this toxin family accounted for approximately half of the identified expressed sequence tags \[[@B22]\]. In *M. fulvius*, 3FTxs only accounted for 9.7% of the total reads, reflecting vast differences in expression patterns within the genus.

### Long-chain neurotoxins

Long-chain neurotoxins (LCNs) were the third most abundant and fourth most diverse toxin class. We identified nine sequences, which grouped into seven clusters and accounted for 4.0% of toxin reads and 1.8% of the total reads (Figure [2](#F2){ref-type="fig"}). LCNs are similar to the short-chain 3FTxs described above but contain an additional 6--12 amino acid residues and an additional disulfide bond \[[@B21]\]. While both antagonize muscle nicotinic acetylcholine receptors, differences in the functional sites of these toxins correlate to differences in the specificity of their targets \[[@B21]\]. LCNs were much more similar to one another than 3FTxs, being 5.3% divergent at the nucleotide level and 12.8% divergent at the amino acid level whereas divergence among members of the 3FTx class was extremely high, with a paucity of conserved nucleotides and amino acids across cluster members.

### Snake venom metalloproteinases

SVMPs were the fourth most abundant toxin class, represented by a single transcript which accounted for 2.9% of the toxin reads and 1.3% of the total reads (Figure [2](#F2){ref-type="fig"}). SVMPs display extensive local and systemic hemorrhagic activity associated with envenomation in viperids, but the role of these enzymes following *Micrurus* envenomation is uncertain. These enzymes can be subdivided into classes based on differences in domain structure, and the transcript identified in the venom-gland transcriptome of *M. fulvius* is a member of the class SVMP-III, characterized by disintegrin-like, cysteine-rich, and metalloproteinase domains \[[@B23]\]. Larger molecular weight toxins, such as SVMPs, are often absent from elapid venoms and are more common components in the venoms of viperids \[[@B16],[@B23]\]. High metalloproteinase expression has been shown to be incompatible with high toxicity in rattlesnakes, being described by Mackessy as a tradeoff between neurotoxicity and hemorrhagic activity \[[@B24]\]. High-molecular weight toxins such as SVMPs are the major causes of hemorrhage and necrosis commonly associated with viperid envenomations, and presumably aid in digestion and are most effective when localized at the site of the bite. Conversely, toxins with systemic effects (e.g., toxicity) such as 3FTxs are more effective when spread through the envenomated organism is rapid, resulting in prey immobilization. This dichotomy in pharmocological effects appears to hold in elapids as well, demonstrating the antagonistic effects of these components. Yet in comparison to other transcriptomic work with *Micrurus* species, SVMP expression levels are nearly five-times higher in *M. fulvius* than in congeneric individuals \[[@B22]\], suggesting a more active functional role for this toxin in *M. fulvius*. This hypothesis awaits proteomic verification and testing via comparative functional assays to quantify the activity of SVMPs in *M. fulvius* relative to congeners.

### Kunitz-type inhibitors

Kunitz-type inhibitors (KUNs) were the fifth most abundant and third most diverse toxin class present in the *M. fulvius* transcriptome, with nine transcripts and eight clusters accounting for 2.2% of the toxin reads and 1.0% of the total reads (Figure [2](#F2){ref-type="fig"}). KUNs are characterized by possessing a compact tertiary fold and three disulfide bonds, functioning as both inhibitors of serine proteases and as neurotoxins by inhibiting calcium and potassium ion channels \[[@B25]\]. KUN-4 was a very divergent transcript, being 504 nucleotides longer than the next longest transcript. It shared 92.0% identity with a putative KUN known from the Australian elapid *Austrelaps labialis*\[[@B26]\] and 85.0% identity with a KUN identified in the venom-gland transcriptome of *C. adamanteus*\[[@B16]\]. This transcript is considered putative until a comprehensive functional characterization is completed. The removal of this extremely divergent transcript resulted in a maximum pair-wise nucleotide divergence of 31.0% within KUNs and a maximum pair-wise amino acid divergence of 68.0%, reflecting the diversity of this toxin class, especially in comparison to LCNs.

### Low-abundance toxins

PLA~2~s, 3FTxs, LCNs, SVMPs, and KUNs accounted for 95.1% of the reads mapping to toxin sequences (Figure [1](#F1){ref-type="fig"}B), 82.7% of the toxin clusters, and 85.3% of the unique toxin transcripts. The remaining low-abundance toxins fell into ten different classes, are listed under "Other" in Figure [1](#F1){ref-type="fig"}B and Figure [2](#F2){ref-type="fig"}, and are described in Table [2](#T2){ref-type="table"}.

###### 

Low abundance toxin classes

   **Toxin class**   **Clusters**   **Sequences**   **% toxin reads**   **% total reads**                        **Putative function**
  ----------------- -------------- --------------- ------------------- ------------------- ------------------------------------------------------------------
         CTL              2               3               0.80                0.365                       Disruption of hemostasis \[[@B27]\]
        CREGF             1               1               0.01                0.007                 Substrate recognition and specificity \[[@B28]\]
        HYAL              1               1               0.20                0.089                     Degradation of extracellular matrix and
                                                                                                     connective tissue; spreading factor \[[@B29]\]
        LAAO              1               3               0.88                0.403                    Edema, platelet aggregation, and apoptosis
                                                                                                     due to the liberation of peroxides \[[@B30]\]
         NP               1               1               0.70                0.321                              Hypotension \[[@B3]\]
         NGF              1               2               0.58                0.264               Induction of apoptosis in neuronal cells \[[@B31]\]
         NUC              1               1               0.23                0.103                    Liberation of toxic nucleosides \[[@B32]\]
         PDE              1               1               0.11                0.052            Hydrolysis of phosphodiester bonds; hypotension \[[@B32]\]
         PLB              1               1               0.34                0.154         Unknown; potentially hemolytic and/or cytotoxic \[[@B2],[@B33]\]
        VEGF              3               3               1.05                0.479         Hypotension and augmentation of vascular permeability \[[@B34]\]

Abbreviations. *CTL* C-type lectin, *CREGF* Cysteine-rich with EGF-like domain, *HYAL* hyaluronidase, *LAAO* L amino-acid oxidase, *NP* natriuretic peptide, *NGF* nerve growth factor, *NUC* nucleotidase, *PDE* phosphodiesterase, *PLB* phospholipase B, *VEGF* vascular endothelial growth factor.

Heterozygosity and gene duplication
-----------------------------------

Single nucleotide polymorphisms (SNPs) were identified in the coding regions of toxin clusters and nontoxin sequences using the SeqMan module from the DNAStar Lasergene software suite following a templated alignment in NGen. We analyzed 2,025 contigs and detected 98 SNPs in 78 transcripts (Table [3](#T3){ref-type="table"}). Of these 78 transcripts, 69 coded for nontoxin proteins while the remaining nine SNP-containing transcripts were identified as toxins. Ten of the 69 nontoxin transcripts and two of the nine toxin sequences with variable sites contained multiple SNPs. A total of 87 SNPs were spread over 3.7% of nontoxin transcripts while 11 SNPs were found over 12.0% of toxin cluster sequences. Of the SNPs identified in nontoxin transcripts, 26.4% resulted in alterations to the amino-acid sequence, while 45.5% of the SNPs identified in toxin transcripts resulted in a nonsynonymous mutation. Overdominant selection favors polymorphism and increases genetic variability. Synonymous SNPs are often predicted to be invisible to the sieve of selection, and elevated nonsynonymous rates at polymorphic toxin loci suggest that the diversity of toxin genes can at least, in part, be explained by overdominant selection. Our SNP calling approach only identified polymorphic sites as SNPs if the nucleotide occurred with a frequency ranging from 40--60%. Therefore, sequences possessing SNPs were considered putative heterozygous loci, and we compared the frequency of heterozygous loci between classes to a *χ*^2^ distribution with one degree of freedom. Toxin and nontoxin sequences accounted for 5.6% and 94.4% of the total annotated transcripts, respectively. The frequency of heterozygous toxin loci was significantly greater than the frequency of heterozygous nontoxin sequences ( *χ*^2^ = 6.383,*df* = 1,*p* = 0.0115). Toxin transcripts also possessed a much higher SNP density than nontoxins. SNP density was calculated as the number of SNPs per 1,000 bases (kb) in the coding regions of toxin and nontoxin transcripts containing SNPs \[[@B35]\]. Nontoxin transcripts had a SNP density of 0.96 SNPs/kb while toxins had a SNP density of 1.93 SNPs/kb.

###### 

Putative SNPs in 69 of the 1,950 nontoxin and nine of the 75 toxin sequences

  **Transcript**                                        **Type**   **Coverage**   **Position**   **SNP%**   **Amino acid**    
  ---------------------------------------------------- ---------- -------------- -------------- ---------- ---------------- ---
  40S ribosomal protein S14                             Nontoxin       762            292          52.0           D           
  40S ribosomal protein S18                             Nontoxin       284            424          47.2           N           
  40S ribosomal protein S23                             Nontoxin       510             97          51.2           K           
  6-phosphogluconate dehydrogenase                      Nontoxin        33            624          54.5           V           
  60S ribosomal protein L29                             Nontoxin       411             45          51.3           K           
  60S ribosomal protein L32                             Nontoxin       525            332          47.8           K           
  Actin-related protein 2/3 complex subunit 3           Nontoxin        30            255          50.0           R           
  Alanine aminotransferase 2-like protein               Nontoxin        23            241          43.5           T           
  Alpha globin                                          Nontoxin        26            435          50.0          F →L         
  Aminopeptidase N                                      Nontoxin        32           2,592         46.9          R →C         
  Annexin A2                                            Nontoxin        66            302          42.4          T →A         
  Annexin A4                                            Nontoxin       286            248          44.4           A           
  Annexin A5                                            Nontoxin        99            236          50.5           S           
  ATP synthase H + transporting mitochondrial F0        Nontoxin       109            178          45.9           L           
  Bifunctional heparan sulfate N-deacetylase/           Nontoxin        20           2,445         45.0          M →T         
  N-sulfotransferase 2-like protein                                                                                           
  C4orf34                                               Nontoxin      1,021           175          48.5           A           
  Caprin-1                                              Nontoxin        46           1,327         45.7          S →P         
  Cell cycle progression protein 1                      Nontoxin        22            708          45.5           G           
                                                                        52           2,286         42.3          K →E         
  Cellular nucleic acid-binding protein                 Nontoxin        83            156          56.6           T           
  Chloride intracellular channel protein 1              Nontoxin       112            447          58.0           D           
  Clathrin interactor 1                                 Nontoxin        36           1,731         50.0           P           
  Cyclic AMP-responsive element-binding protein 3       Nontoxin        25            482          44.0           D           
  Cytochrome c oxidase subunit 4                        Nontoxin        76            227          47.4          E →A         
  Dynactin subunit 6 1                                  Nontoxin        35            424          51.4           I           
  Ectonucleoside triphosphate diphosphohydrolase 7      Nontoxin        27            901          48.1          K →E         
  Endoplasmic reticulum oxidoreductin 1-Lbeta           Nontoxin       260           1,247         54.6           G           
  EPS8                                                  Nontoxin        49           2,112         49.0          Q →H         
  Eukaryotic initiation factor 4A-1                     Nontoxin        29            409          44.8           H           
                                                                        24            496          41.7           R           
                                                                        32            559          53.1           D           
  Eukaryotic translation elongation factor 1 gamma      Nontoxin       313            908          50.5           I           
  Eukaryotic translation initiation                     Nontoxin        43             73          41.9           I           
                                                                        40           1,067         47.5           H           
  Eukaryotic translation initiation factor 2 subunit    Nontoxin        37           1,172         51.4           L           
  Eukaryotic translation initiation factor 3            Nontoxin        42           3,200         52.4           G           
  Eukaryotic translation initiation factor 5A-1         Nontoxin        71             77          45.1           D           
                                                                        75             86          45.3           T           
                                                                        98            143          48.0           N           
                                                                       139            384          56.1           R           
                                                                       108            447          52.8           S           
                                                                        72            486          54.2           T           
  Fructose-1,6-bisphosphatase 1                         Nontoxin        54           1,078         44.4           R           
  GABA                                                  Nontoxin        31            144          45.2           R           
                                                                        42            159          54.8           D           
  Guanine nucleotide-binding protein                    Nontoxin        30            569          46.7          A →T         
  Guanine nucleotide-binding protein subunit beta-2     Nontoxin       541            149          51.2           T           
  Hydroxyacylglutathione hydrolase                      Nontoxin        21            190          52.4          W →R         
                                                                        23            709          47.8          S →P         
  Integrin-linked protein kinase                        Nontoxin        29           1,205         55.2           A           
  Interferon-related developmental regulator 2          Nontoxin        22            709          45.5          A →T         
                                                                        23            709          47.8          S →P         
  Integrin-linked protein kinase                        Nontoxin        29           1,205         55.2           A           
  Interferon-related developmental regulator 2          Nontoxin        22            709          45.5          A →T         
  LAG1 longevity assurance protein 2                    Nontoxin        41            896          53.7           T           
  LAMTOR2                                               Nontoxin        81            468          53.1           L           
  LIM domain and actin-binding protein                  Nontoxin        28           1,516         50.0          V →A         
  Lysine-specific histone demethylase 1B                Nontoxin        70            122          44.3          D →G         
  Lysosomal cobalamin transporter                       Nontoxin        27            184          48.1           A           
  Malate dehydrogenase                                  Nontoxin        68           1,059         57.4           L           
  Mannose-1-phosphate guanyltransferase beta            Nontoxin        32            698          53.1          P →S         
  Microspherule protein 1                               Nontoxin        24            665          50.0          V →A         
  Minor histocompatibility antigen H13 1                Nontoxin       452           1,164         53.5          P →L         
  MTP4                                                  Nontoxin      1,664           503          59.3           D           
                                                                      1,480          1,621         49.8          P →S         
  NADH dehydrogenase                                    Nontoxin        40            213          40.0          I →V         
  NADPH-cytochrome P450 oxidoreductase                  Nontoxin        28            286          53.6           T           
  Nuclease-sensitive element-binding protein 1          Nontoxin        91            675          56.0           R           
  Polyubiquitin-C isoform 2                             Nontoxin       892            350          57.4           G           
                                                                       637            560          52.3           F           
                                                                       593            635          51.8           K           
                                                                       774            917          52.8           A           
                                                                       697            950          49.6           S           
  Proteasome                                            Nontoxin        83            430          59.0           F           
  Proteasome subunit alpha type-6                       Nontoxin        48            139          52.1           H           
  Protein disulfide-isomerase A3                        Nontoxin       146            196          50.0           C           
  Sarcolemmal membrane-associated protein-3             Nontoxin        21           1,534         42.9           Q           
  SEC31                                                 Nontoxin       110           2,866         46.4           P           
  Serine/threonine-protein phosphatase                  Nontoxin        22           1,144         40.9          T →S         
                                                                        22           1,337         45.5           S           
  Sialin                                                Nontoxin        23            321          43.5           P           
  Sodium/glucose cotransporter 4                        Nontoxin        26            579          57.7          S →C         
                                                                        26            580          57.7          S →T         
  Stress-induced-phosphoprotein 1                       Nontoxin        22            455          50.0           L           
                                                                        21            716          52.4           K           
  Transmembrane emp24 domain-containing                 Nontoxin       347            595          46.1           Y           
  Tubulin beta-5 chain                                  Nontoxin        27           1,340         44.4           A           
  V-type proton ATPase catalytic subunit A              Nontoxin        63           1,344         55.6           I           
  Y box binding protein 1                               Nontoxin        91            811          59.3           R           
  YTH domain family protein 1                           Nontoxin        25           1,347         44.0           P           
  C-type lectin 1a                                       Toxin        7,320           360          55.1           G           
  C-type lectin 2                                        Toxin         130            598          48.5           N           
  Cysteine-rich with EGF-like domain 1                   Toxin          48            257          50.0           K           
                                                                        82            949          45.1           T           
  Kunitz inhibitor 1a                                    Toxin        12,402          280          42.5          G →R         
  L-amino acid oxidase 1a                                Toxin        1,850           769          55.0           Y           
                                                                      3,094          1,158         41.2          H →Q         
  Long chain neurotoxin 3                                Toxin        7,081           402          40.1          V →I         
  Phospholipase A~2~ 31                                  Toxin          20             62          40.0           S           
  Phospholipase A~2~ 9                                   Toxin          68             44          50.0          N →I         
  Venom nerve growth factor 1a                           Toxin        3,689           316          49.3          P →S         

Sequences in multitranscript clusters appear to represent different allelic states of heterozygous loci, potentially reflecting how heterozygote advantage can favor gene duplication. If duplicate genes confer an advantage by providing more of a specific gene product, duplication events involving genes that are already highly expressed would be most beneficial \[[@B36]\]. While duplication events of highly expressed toxin transcripts within the snake venom gland have been rampant throughout the evolutionary history of venomous species (e.g., the formation of large gene families), this does not explain the increased heterozygosity detected in our analyses. Gene duplication may also produce a selective advantage when overdominance occurs. In this scenario, carrying different alleles at a single locus is beneficial and gene duplication can ultimately result in the fixation of multiple advantageous alleles. Heterozygosity occurred with a significantly higher frequency in toxin than in nontoxin sequences with nearly half of the polymorphic sites in toxins resulting in a nonsynonymous mutation, suggesting that heterozygote advantage may play a key role in driving gene duplication and allelic variation within toxin genes \[[@B37]\] (but see \[[@B38]\]).

Expression biases and sequence divergence following speciation
--------------------------------------------------------------

The maximum-likelihood phylogeny for 15 unique *M. fulvius* 3FTx cluster members was estimated under the HKY+G model (Figure [3](#F3){ref-type="fig"}A). Expression levels were extremely biased toward a handful of sequences; four transcripts accounted for more than 67.0% of the toxin reads mapping to 3FTxs. These high-abundance transcripts (3FTx-1a, 2a, 3a, and 4a) are all members of multitranscript clusters, and duplication events and the number of alleles appear to be positively correlated with expression within the 3FTx toxin gene family. The maximum-likelihood phylogeny for 15 *M. fulvius* 3FTx clusters and 23 3FTx transcripts from *M. altirostris* and *M. corallinus* was estimated under the HKY+G model (Figure [3](#F3){ref-type="fig"}B). Two of the four most highly expressed *M. fulvius* 3FTx paralogs are in well-supported clades con- taining orthologs from both *M. altirostris* and *M. corallinus*. 3FTx-13, while accounting for approximately 2.0% of the 3FTx reads in *M. fulvius*, is in a well supported clade containing ten *M. altirostris* sequences indicating that orthologs to 3FTx-13 have undergone duplication events in *M. altirostris*. *M. altirostris* sequences were identified in a venom-gland transcriptome analysis where the toxin family accounted for 52.8% of the 867 expressed sequence tags generated \[[@B22]\], demonstrating that these transcripts are highly expressed. The apparent dominance of the 3FTx toxin family in *M. altirostris* by these transcripts, and the extremely low expression of 3FTx-13 in *M. fulvius* could reflect dietary differences between the species, as shifts in prey consumption have been known to be coupled with expression modifications that augment venom efficacy \[[@B4]\]. Genes that are no longer effective are lost or silenced while effective genes are highly expressed and diversify, suggesting functional divergence among toxins occurs following speciation events \[[@B4]\].

![**The expression of three-finger toxins was extremely biased in*Micrurus fulvius*.** Expression of three-finger toxin (3FTx) sequences was dominated by several multitranscript cluster members, suggesting a significant role for recent gene duplication within the gene family. A homologous toxin sequence from the mangrove snake (*Boiga dendrophila*) was used as an outgroup to root the phylogeny. Bayesian posterior probability values exceeding 50% are shown. Adjacent bars indicate expression levels relative to the most highly expressed member of the class, with a completely filled bar indicating the most highly expressed transcript of the class. **(A)** A maximum-likelihood phylogeny of *M. fulvius* 3FTx clusters under the HKY+G model. 3FTx expression levels were dominated by a handful of sequences, all representatives of multitranscript clusters (as indicated by the letter following the cluster number), suggesting a relationship between gene duplication and expression. **(B)** A maximum- likelihood phylogeny of *M. fulvius* transcripts identified in this study as well as orthologous 3FTx transcripts from *M. corallinus* and *M. altirostris* under the HKY+G model. Tips are color-coded by species. The subclade containing nine *M. altirostris* transcripts is sister to a sub-clade containing a single *M. altirostris* sequence and 3FTx-13 from *M. fulvius*. 3FTx-13 is expressed at a relatively low level, suggesting that the divergence of toxins occurs following speciation, at least for this one 3FTx paralog.](1471-2164-14-531-3){#F3}

A maximum-likelihood phylogeny for 31 unique *M. fulvius* PLA~2~ clusters was estimated under the SYM+G model (Figure [4](#F4){ref-type="fig"}A). Expression levels for PLA~2~ transcripts were much more evenly distributed across the entire gene family in comparison to 3FTx sequences. The most highly expressed 3FTx transcript, 3FTx-2a, accounted for 22.7% of the total 3FTx reads while four transcripts accounted for approximately 67.0% of the 3FTx reads. In the PLA~2~ gene family, PLA~2~-2a was the most abundant toxin family member, accounting for 8.3% of the total PLA~2~ reads and the four most highly expressed transcripts accounted for only 30.8% of the reads mapping to PLA~2~s. Although these two families dominated toxin transcript expression levels in the *M. fulvius* venom gland, PLA~2~s did so through uniform expression while 3FTx expression patterns were tremendously biased. PLA~2~ transcripts also demonstrated less sequence divergence among clusters relative to 3FTx sequences. PLA~2~s are esterolytic enzymes that share a conserved three-dimensional structure \[[@B4],[@B20]\], and the greater similarity between PLA~2~ transcripts may be a result of more stringent conformational constraints. The conservation of crucial structures in PLA~2~ enzymes ensures a functioning active site whereas the relatively short 3FTx peptides may be free of this limitation. Lynch \[[@B4]\] found that functionally critical sites were under strong purifying selection in PLA~2~s, with strong directional selection being restricted to surface residues due to their interactions with specific targets in prey, enabling prey-specific adaptation while ensuring the functionality of the enzyme. The maximum-likelihood phylogeny for 31 *M. fulvius* PLA~2~ clusters, three *M. altirostris* sequences, and a single *M. corallinus* sequence was estimated under the SYM+G model (Figure [4](#F4){ref-type="fig"}B). Functional divergence among PLA~2~s may also occur following speciation events \[[@B4]\], as all three *M. altirostris* sequences constitute a monophyletic clade and are sister to PLA~2~-21, a transcript that accounts for \<1% of PLA~2~ reads in *M. fulvius* (although the pattern is not as strong as in 3FTxs as the PLA~2~-21/ *M. altirostris* clade is not well-supported).

![**The expression of phospholipases A**~**2**~**was uniform across transcripts in*Micrurus fulvius*.** The phospholipase A~2~ (PLA~2~) gene family was characterized by an even distribution of expression levels. A homologous toxin sequence from the eastern diamondback rattlesnake (*Crotalus adamanteus*) was used as an outgroup to root the phylogeny. The root branch was shortened for visual clarity and is indicated by the dashed line. Bayesian posterior probability values exceeding 50% are shown. Adjacent bars indicate expression levels relative to the most highly expressed member of the class, with a completely filled bar indicating the most highly expressed transcript of the class. **(A)** A maximum-likelihood phylogeny of *M. fulvius* PLA~2~ clusters under the SYM+G model. PLA~2~ expression levels were much more evenly distributed throughout the class in comparison to 3FTx transcript expression levels (Figure [4](#F4){ref-type="fig"}). **(B)** A maximum-likelihood phylogeny of *M. fulvius* transcripts identified in this study as well as orthologous PLA~2~ transcripts from *M. corallinus* and *M. altirostris* under the SYM+G model. Tips are color-coded by species. The sub-clade containing the *M. altirostris* transcripts again suggests divergence among toxins may occur following speciation events.](1471-2164-14-531-4){#F4}

Rampant gene duplication following the initial recruitment of toxin genes into the venom gland has led to the production of multigene toxin families \[[@B36]\], including the highly expressed 3FTx and PLA~2~ gene families present in the *M. fulvius* transcriptome. Gene duplication can be advantageous by increasing the production of a beneficial gene product or permanently fixing multiple advantageous alleles. Gene duplication can be followed by elevated rates of selection \[[@B39]\], enabling genes to acquire new functions or divide single functions among several genes \[[@B36]\]. Phylogenetic analyses of the 3FTx and PLA~2~ toxin classes (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}) demonstrate the pervasiveness of gene duplication throughout the evolutionary history of these toxin families, and suggest that the divergence of toxin genes occurs following speciation. Zhang \[[@B36]\] stated that species-specific duplication events can result in species-specific gene function and, subsequently, adaptation. This adaptation can result in divergence and the development of unique phenotypes \[[@B36]\], which may be reflected in our phylogenetic analyses of multiple *Micrurus* species.

Intragenomic evolution of venom genes
-------------------------------------

Positive selection in toxin genes has been repeatedly documented, reflecting the significance of venom to the fitness of venomous species \[[@B2]-[@B4]\]. Selection analyses have taken a somewhat unsystematic approach, analyzing all sequences available with little regard for the evolutionary histories of the taxa involved \[[@B4],[@B40]\]. Here, we examine the intragenomic evolution of toxin classes within the *M. fulvius* genome. The codeml results for detecting the presence of positive selection are summarized in Table [4](#T4){ref-type="table"}. The results from the M7 and M8 models are nearly identical to the results from the M1 and M2 models and are therefore not shown. We examined 3FTxs, KUNs, LCNs, and PLA~2~s for the presence of positive selection as these represent the four most diverse and four of the five most abundant toxin classes identified. While the fourth most highly expressed toxin class was SVMPs, this class was represented by a single transcript and thus could not be included in our analyses.

###### 

Summary of codeml results

   **Class**   ***n*/Model**   **M1: Nearly neutral**   **−ln*L***   **M2: Positive selection**   **−ln*L***   **M0:*ω***   ***λ***    ***p-value***
  ----------- --------------- ------------------------ ------------ ---------------------------- ------------ ------------ --------- -----------------
     3FTx           26             *p*: 0.27 0.73        1,600.40       *p*: 0.13 0.31 0.56        1,576.50       1.48       47.8     4.17 ×10^−11^\*
                   F81+G           *ω*: 0.11 1.00                       *ω*: 0.00 1.00 3.79                                                   
      KUN            9             *p*: 0.32 0.68         965.08        *p*: 0.31 0.45 0.24         962.16        0.58       5.84      5.39 ×10^−2^
                   GTR+G           *ω*: 0.02 1.00                       *ω*: 0.03 1.00 2.74                                                   
      LCN            9             *p*: 0.86 0.14         315.85        *p*: 0.84 0.00 0.16         305.84       999.00      20.02    4.49 ×10^−5^\*
                   JC+I            *ω*: 1.00 1.00                      *ω*: 0.00 1.00 999.00                                                  
    PLA~2~          52             *p*: 0.66 0.34        4,761.33       *p*: 0.49 0.28 0.23        4,359.71       3.32      443.24        0.00\*
                   SYM+G           *ω*: 0.05 1.00                       *ω*: 0.04 1.00 11.68                                                  

*dN/dS* ratios are represented by *ω*; *λ* represents our test statistic which is negative twice the difference in log likelihoods compared across models to a *χ*^2^ distribution with two degrees of freedom; and *p* corresponds to the proportion of codon sites falling into one of three rate classes which are purifying selection, neutral selection, and positive selection, respectively. The model selected by MrModelTest2.3 \[[@B50]\] for the estimation of the maximum-likelihood phylogeny is given and *n* corresponds to the number of sequences used in the analysis. Significant p-values are indicated by an asterisk.

The M0 model estimates a single *ω* value over all branches in the phylogeny and therefore is only capable of detecting evidence of selection when the majority of sites have experienced positive selection throughout their evolutionary histories \[[@B4]\]. Under the M0 model, we detected strong evidence of positive selection ( 1.48≤*ω*≤999.00) for the 3FTx, LCN, and PLA~2~ toxin families. Evidence of positive selection was not detected in the KUN toxin family ( *ω*=0.58), and the extraordinarily high *ω* calculated for the LCN family ( *ω*=999.00) was a result of all polymorphic sites resulting in nonsynonymous substitutions. We also used site specific models (M1, M2, M7, and M8) to detect rate variation among sites \[[@B2],[@B4]\]. The 3FTx, LCN, and PLA~2~ toxin classes rejected the null or nearly neutral model (M1) in favor of the selection model (M2) ( 0.00≤*p*≤4.49×10^−5^), demonstrating the pervasiveness of positive selection experienced by highly expressed toxin transcripts within the *M. fulvius* genome. The percentage of sites experiencing selection ranged from 16--56% with 3.79≤*ω*≤999.00. The KUN toxin class did not reject the M1 model in favor of the selection model ( *p*=0.0539). The high *ω* value under the site specific models for the LCN class again reflects the absence of synonymous substitutions within the class. Elevated rates of evolution have previously been documented in toxin genes \[[@B2],[@B4],[@B41],[@B42]\], and this accelerated evolution is most likely due to their direct involvement in fitness \[[@B2],[@B4]\] and may be reflective of a coevolutionary arms race with specific prey taxa \[[@B6],[@B7]\].

Sequence accession numbers
--------------------------

The original, unmerged reads were submitted to the National Center for Biotechnology Information (NCBI) Sequence Read Archive under accession number SRA062772. The annotated sequences were submitted to the GenBank Transcriptome Shotgun Assembly database under accession numbers GAEP01000001--GAEP01001950 (nontoxins) and GAEP01001951--GAEP01002066 (toxins).

Conclusions
===========

We have described the most comprehensive transcriptomic characterization of an elapid venom gland to date, revealing venom complexity previously unknown from any New World coral snake \[[@B11],[@B13],[@B15],[@B22],[@B43]-[@B45]\]. Transcriptional effort expended on toxins relative to nontoxins may differ between venoms dominated by high-molecular weight components and venoms dominated by smaller proteins. This reduction in the machinery required for the production of functional toxins may confer a metabolic advantage to species expressing smaller peptides and enzymes, but may also reduce the capacity of species to evolve effective counterdefenses to resistant prey or predators. Toxin expression was dominated by PLA~2~s and 3FTxs, yet these two gene families greatly differed in expression patterns. Expression within the 3FTx family was extremely biased, being dominated by a handful of transcripts while PLA~2~ expression was much more uniform. SNP analysis revealed the frequency of heterozygous loci was significantly higher in toxins than in nontoxins with nearly half of the polymorphic sites in toxins resulting in a nonsynonymous substitution, suggesting overdominance may ultimately favor gene duplication and permanent fixation of advantageous alleles within the venom gland. We detected evidence of positive selection in three of the four most diverse and highly expressed toxin classes; sequence evolution or modifications of toxin expression patterns could increase the specificity of venoms for frequently envenomed prey items \[[@B5]\]. Diet has been proposed to be an important selective regime in determining venom composition within *Micrurus* species \[[@B46]\], and elevated rates of selection suggest a coevolutionary arms race \[[@B1]\].

Methods
=======

Venom-gland transcriptome sequencing
------------------------------------

We followed the approach described in Rokyta et al. \[[@B16]\] for the preparation and sequencing of the venom gland. We sequenced the venom-gland transcriptome of an adult female *M. fulvius* from Wakulla County, FL, with a snout-to-vent length of 620 mm and a total length of 685 mm. The snake was anesthetized by propofol injection (10 mg/kg), and venom was extracted by electrostimulation \[[@B47]\]. The animal was allowed to recover for four days for transcription to be maximized \[[@B48]\], at which point the snake was euthanized by sodium pentobarbitol injection and its venom glands removed \[[@B16]\]. This procedure was approved by the Florida State University Institutional Animal Care and Use Committee under protocol \#0924. Sequencing and nonnormalized cDNA library preparation was performed by the HudsonAlpha Institute for Biotechnology Genomic Services Laboratory (<http://www.hudsonalpha.org/gsl/>). Total RNA was reduced to poly-A + RNA with oligo-dT beads. Two rounds of poly-A + selection were performed. The mRNA then underwent a mild heat fragmentation followed by random priming for first-strand synthesis. Standard second-strand synthesis was followed by library preparation with the double-stranded cDNA as input material. Sequencing was performed in a single lane on the Illumina HiSeq 2000 with 100-base-pair, paired-end reads.

Transcriptome assembly and analysis
-----------------------------------

We followed the general approach described in Rokyta et al. \[[@B16]\] for the *de novo* assembly of the *M. fulvius* venom-gland transcriptome. Most of our read pairs overlapped at the 3' end and these reads were subsequently merged to produce longer, composite reads \[[@B16],[@B17]\]. Quality scores were updated accordingly and only these merged reads were used in the assembly process. The Extender program \[[@B16]\] was used as a *de novo* assembler of 1,000 random reads to eliminate extremely high-abundance transcripts. Full-length transcripts were identified with blastx searches and annotated. These sequences were then used as a template to filter a set of the unassembled, original merged reads using NGen 3.1 and a minimum match percentage of 98%. This *de novo* approach using the Extender program was repeated a second time as described above, using 1,000 of the filtered reads as the program continued to be productive at assembling full-length, unique transcripts. We next identified nontoxin transcripts by aligning 10 million of the unassembled reads to nontoxin transcripts previously identified in the venom-gland transcriptome of *C. adamanteus*\[[@B16]\] using the NGen assembler. We performed an initial alignment with a minimum match percentage of 93%. We then performed a second alignment with a reduced minimum match percentage of 90% to assemble more divergent transcripts. All other parameter values were consistent with our *de novo* assemblies in NGen. Coding regions with minimum ten-fold coverage were annotated, and all regions below this threshold were removed. These transcripts were combined with the Extender results and this unique set of sequences was then used as a template to filter a set of the merged reads using NGen 3.1 and a minimum match percentage of 98%. Next, 10 million filtered reads were used in a *de novo* assembly with NGen 3.1 with a minimum match percentage of 93%. Contigs with a minimum of 200 reads were identified with blastx searches, annotated, and duplicates removed, producing a unique set of identified transcripts. This process of filtering, NGen assembly, and annotating was performed an additional two times. Abundances were estimated by mapping 10 million merged reads to full-length sequences with a minimum match percentage of 95% using a reference-based assembly in NGen \[[@B16]\]. The percentage of reads mapping to an individual transcript was used to estimate abundance. Toxin transcripts were clustered based on \<1% nucleotide divergence for abundance estimates.

Detecting heterozygosity
------------------------

Ten million merged reads were aligned to the 2,025 annotated transcripts in a reference-based assembly in NGen with a minimum match percentage of 95%. SNPs were identified by using the SeqMan module of the DNAStar Lasergene software suite. Toxin transcripts were clustered based on \<1% nucleotide divergence as SNP detection provided an approach to identify allelic variation within toxin clusters. SNPs were only considered if they occurred in the coding sequence of full-length, annotated transcripts, had a SNP% ranging from 40--60%, and at least 20-fold coverage with maximum coverage bounded at 20,000-fold. These parameters are more stringent than previous SNP identification approaches \[[@B35]\] and provide a conservative estimation of variable sites in the coding regions of annotated transcripts. The frequency of toxin versus nontoxin heterozygous loci, relative to the number of transcripts belonging to each class identified in the transcriptome, was compared to a *χ*^2^ distribution with one degree of freedom.

Phylogenetic analyses
---------------------

Sequences of 3FTxs and PLA~2~s were independently aligned on the basis of the amino-acid sequence in the MegAlign module of the DNAStar Lasergene software suite with ClustalW \[[@B49]\]. Model selection was performed using the Akaike Information Criterion values with MrModelTest2.3 \[[@B50]\], and maximum-likelihood phylogenies were estimated using PAUP\* version 4.0a126 \[[@B51]\] and the iterative search strategy described by Rokyta et al. \[[@B52]\]. Nodal support was determined in MrBayes v3.1.2 by the estimation of Bayesian posterior probabilities \[[@B53],[@B54]\]. Markov Chain Monte Carlo searches were run for 10 million generations with four chains and a temperature parameter of 0.20. Samples were taken every 1,000 generations and the first million generations were discarded as burn-in. A related transcript from the mangrove snake (*Boiga dendrophila*: Colubridae) served as the outgroup to root each 3FTx phylogeny while a transcript from the eastern diamondback rattlesnake (*C. adamanteus*) served as the outgroup to root each PLA~2~ phylogeny. Orthologous transcripts of both toxin families from congeners were downloaded from the NCBI database and included in a second analysis following the method described above.

Detecting selection
-------------------

Transcripts from the four major toxin families (3FTx, KUN, LCN, and PLA~2~) were used in selection analyses. Sequences were independently aligned according to class on the basis of the amino-acid sequence in the MegAlign module of the DNAStar Lasergene software suite with ClustalW \[[@B49]\]. Gaps, stop codons, and signal peptides were excluded from all analyses, and only transcripts possessing signal peptides were included. Signal peptides mediate the targeting and transporting of the pre-protein and are cleaved prior to expression \[[@B55]\]. Their exclusion from our analyses ensured that only the mature amino-acid sequences of expressed toxins that are targets of selection were examined. Model selection was performed using the Akaike Information Criterion values with MrModelTest2.3 \[[@B50]\]. A maximum likelihood phylogeny was constructed using PAUP\* version 4.0a126 \[[@B51]\] and the iterative search strategy previously described by Rokyta et al. \[[@B52]\].

A likelihood-ratio test for positive selection was conducted with codeml from the PAML version 4.4 package \[[@B56],[@B57]\] with the maximum-likelihood phylogeny estimated as described above \[[@B2]\]. The null model, or the nearly neutral model (M1), allows for a class of sites to be evolving under neutral selection (*dN/dS*=1) while constraining the *dN/dS* for a second class to be \<1. The alternative model, or the positive selection model (M2), incorporates an additional class that allows for a proportion of codon sites to be experiencing positive selection (*dN/dS* \>1). To test for the presence of positive selection, negative twice the difference in log likelihoods were compared between models to a *χ*^2^ distribution with two degrees of freedom. A similar test was also performed to verify the results of the initial analysis, comparing models M7 (Beta) and M8 (Beta with positive selection) to a *χ*^2^ distribution with two degrees of freedom \[[@B58]\]. To estimate an overall *dN/dS*, the M0 model was used. This model averages the *dN/dS* across the entire phylogeny, producing a single ratio for all sites. While this model has been shown to have limited power at detecting positive selection \[[@B59]\], it provides a broader perspective and a more conservative estimate of selection within the *M. fulvius* genome than the site-specific models described above.
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3FTx: Three-finger toxin; CTL: C-type lectin; CREGF: Cysteine-rich with EGF-like domain; HYAL: Hyaluronidase; kb: Kilobase; KUN: Kunitz-type protease inhibitor; LAAO: L amino-acid oxidase; LCN: Long-chain neurotoxin; NGF: Nerve growth factor; NP: Natriuretic peptide; NUC: Nucleotidase; PDE: Phosphodiesterase; PLA2: Phospholipase A2; PLB: Phospholipase B; RP-HPLC: Reverse-phase high-performance liquid chromatography; SNP: Single nucleotide polymorphism; SVMP: Snake venom metalloproteinase.
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